Open Menu Close Menu Open Search Close Search

Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed)

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications that propose to identify biomarkers for onset and progression of cognitive impairment in Parkinson’s Disease (PD) through Parkinson’s Disease Dementia (PDD). The use of well-characterized populations of PD and PDD patients that have been, and can continue to be, followed longitudinally with clinical assessments and biospecimen collection to autopsy should be considered.

Application Due Date: March 8, 2019